Kanjinti
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
55513-132 -
Package NDC
55513-132-01 -
Package NDC
55513-132-21 -
Application number
BLA761073 -
SPL ID
0dfd83de-fa6d-43e4-8fb0-4a7c9b134ca7 -
SPL set ID
9a94f5b2-b84e-4987-8ea1-c4346db5a5fa -
UNII
P188ANX8CK -
RxCUI
2174804 -
RxCUI
2174809 -
RxCUI
2257297 -
RxCUI
2257300
What the source publishes
- Labeler
- Amgen, Inc
- Active ingredients
- trastuzumab-anns
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Kanjinti",
"splId": "0dfd83de-fa6d-43e4-8fb0-4a7c9b134ca7",
"labels": [
{
"setId": "9a94f5b2-b84e-4987-8ea1-c4346db5a5fa",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a94f5b2-b84e-4987-8ea1-c4346db5a5fa",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a94f5b2-b84e-4987-8ea1-c4346db5a5fa"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Amgen, Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-01) / 20 mL in 1 VIAL, MULTI-DOSE",
"package_ndc": "55513-132-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20190611"
},
{
"sample": false,
"description": "1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-21) / 20 mL in 1 VIAL, MULTI-DOSE",
"package_ndc": "55513-132-21",
"identifierStatus": "well-formed",
"marketing_start_date": "20250701"
}
],
"productId": "55513-132_0dfd83de-fa6d-43e4-8fb0-4a7c9b134ca7",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "55513-132",
"deaSchedule": null,
"genericName": "trastuzumab-anns",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TRASTUZUMAB",
"strength": "420 mg/20mL"
}
],
"applicationNumber": "BLA761073",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190611",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175661",
"N0000020008"
],
"unii": [
"P188ANX8CK"
],
"rxcui": [
"2174804",
"2174809",
"2257297",
"2257300"
],
"spl_set_id": [
"9a94f5b2-b84e-4987-8ea1-c4346db5a5fa"
],
"pharm_class_epc": [
"HER2/neu Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"HER2/Neu/cerbB2 Antagonists [MoA]"
],
"manufacturer_name": [
"Amgen, Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:55513-132_0dfd83de-fa6d-43e4-8fb0-4a7c9b134ca7"